GLP-1 Not Working? Here's Why — and What to Do Next

By RxPickr Editorial Team

You filled out the intake form, got approved, and started injecting week after week. Maybe four weeks in. Maybe eight. The scale hasn't moved much. Or it moved a little and then stopped entirely. You're wondering if you're the exception — the person GLP-1 medications just don't work for.

Before you give up, it's worth knowing this: "not working" is one of the most searched phrases among people who are actually mid-treatment. The medication often is working. The problem is usually something fixable: a dose that's too low, a quality issue with a compounded product, unrealistic timing expectations, or a provider who's been completely absent since your first prescription was written.

This guide walks through the most common real reasons GLP-1 medications underperform — and what you can actually do about each one.

What "Not Working" Usually Means

Most people who feel like their GLP-1 isn't working fall into one of two categories: they're measuring too early, or they're on the wrong dose.

The STEP 1 trial, which tested once-weekly semaglutide 2.4 mg (the Wegovy dose) in adults with obesity, found a mean body weight reduction of 14.9% at 68 weeks (NEJM, 2021). That result builds gradually — most of the weight loss accumulates between months three and twelve, not in the first few weeks. That slope matters: results accumulate slowly, and the biggest losses typically come between months three and twelve, not weeks two and six.

If you started four to six weeks ago at a starter dose and expected dramatic results, you're measuring at the wrong moment. Starter doses (typically 0.25 mg weekly for semaglutide) are titration steps designed to let your body adjust and minimize nausea. They're not therapeutic weight-loss doses. Most providers titrate up every four weeks, and meaningful appetite suppression often doesn't kick in until you hit a maintenance dose.

But "be patient" is only the right answer if everything else is working correctly. Here's when it isn't.

Common Reasons It May Actually Not Be Working

Your dose is still too low

This is the most common cause, and the most fixable. Semaglutide works on a dose-response curve: higher doses are associated with greater appetite suppression and weight loss, up to a ceiling. If your provider locked you into a low dose and hasn't revisited it, or if the titration schedule has been vague, you may never have reached a dose where the medication has a meaningful effect on your hunger.

Per the Wegovy prescribing information, standard semaglutide titration for weight loss moves from 0.25 mg to 0.5 mg to 1.0 mg to 1.7 mg and finally 2.4 mg, with each step lasting approximately four weeks — reaching the full maintenance dose after about five months. Some providers offer faster titration. Some patients tolerate faster titration well. If you've been on 0.5 mg for three months with minimal side effects and minimal results, the dose is the likely issue.

Medication quality issues with compounded products

Compounded semaglutide is not an FDA-approved finished product. Compounding pharmacies are regulated by state pharmacy boards and, for outsourcing facilities, by the FDA — but they don't go through the same manufacturing validation process that brand-name drugs do. Because compounded semaglutide is not an FDA-approved finished product, it is not subject to the same manufacturing validation and bioequivalence testing requirements as brand-name drugs (FDA compounding overview). Concentration accuracy, stability, and sterility may vary between pharmacies.

Quality can differ between compounding pharmacies. If you've never felt any appetite suppression at doses that should be therapeutic, the formulation is worth investigating. Your provider should be able to share the pharmacy's certificate of analysis, which documents concentration testing results.

Adherence gaps

Weekly injectable medications are easy to miss or misadminister. Common errors include injecting into scar tissue (which absorbs medication poorly), storing the medication outside the recommended temperature range, not rotating injection sites, or simply forgetting doses entirely. Even occasional missed injections break the steady-state concentration that the drug relies on.

If you've been inconsistent, start tracking injections explicitly and make sure your storage conditions are correct (typically refrigerated, protected from light). A few weeks of consistent dosing often reveals whether inconsistency was the hidden variable.

Caloric offset

GLP-1 medications reduce appetite, but they don't eliminate it entirely at lower doses — and they can't override a significant caloric surplus. Some people find the medication dulls cravings for several days after injection, then hunger creeps back before the next dose. Others unconsciously compensate for reduced appetite by eating smaller meals more frequently, which can neutralize the caloric effect.

Tracking food intake for even two weeks can reveal patterns that aren't obvious otherwise. This isn't about blame; it's diagnostic information.

Metabolic factors and non-responders

Some people appear to have limited response to GLP-1 receptor agonists, potentially related to metabolic or physiological factors that aren't fully characterized. True non-response at a fully titrated dose is real but less common than under-dosing or the other issues above. If you've been at or near the maximum dose for two to three months with consistent adherence and minimal weight change, a metabolic evaluation with your provider is worth requesting.

---

---

What to Do About It

Talk to your provider — specifically about dose

Don't ask "is the medication working?" Ask: "What is my current dose, what is the target dose, and what is the schedule to get there?" If your provider can't answer those questions clearly, or if you've been at the same dose for months without a check-in, that's a clinical gap, not a medication failure.

A good provider will also ask about side effects at each dose level, adjust the titration pace if you're struggling with nausea, and document your progress. If those conversations aren't happening, see the section below on switching providers.

Request a dose adjustment

If you're at a sub-therapeutic dose and tolerating the medication well, ask directly for a titration adjustment. Many telehealth providers are willing to accommodate faster titration for patients who have minimal side effects. You're the one who knows your body; it's reasonable to advocate for a faster path to a meaningful dose.

Consider switching from semaglutide to tirzepatide

If you're at a maximum semaglutide dose and have been for at least two to three months with limited response, tirzepatide is worth discussing with your provider. The SURMOUNT-1 trial found that tirzepatide at its highest dose (15 mg) produced a mean body weight reduction of approximately 20.9% at 72 weeks, compared to 14.9% for semaglutide at 68 weeks in STEP 1 (NEJM, 2022). These aren't head-to-head comparisons, but they suggest tirzepatide's dual GIP/GLP-1 mechanism may produce meaningfully greater weight loss for some patients.

Switching medications requires a new prescription and a titration period. Your provider needs to evaluate whether you're a candidate.

Try a microdosing approach if side effects have been the barrier

Some patients never reach a therapeutic dose because they can't tolerate side effects at standard titration speeds. A microdosing approach — starting at a very low dose and titrating more slowly — can allow patients who are sensitive to GI side effects to eventually reach doses that work. Providers like Henry Meds and Noom Med offer dedicated microdose programs.

When the Problem Is Your Provider, Not the Medication

There's a difference between medication that isn't working and a provider who isn't doing their job. Signs your provider may be falling short:

• You haven't had a clinical check-in since your initial prescription was written
• There's no one to contact when you have questions about dosing
• Dose adjustments require waiting weeks for a message response
• No one has reviewed your progress or discussed next steps

In our assessment of major GLP-1 telehealth programs, clinical support varies significantly between providers. Some operate at high volume with minimal follow-up after the initial approval. Others build ongoing provider relationships into the model as a core feature.

If you're not getting adequate support, switching providers is a legitimate option. You don't need a reason beyond "I want more clinical engagement." Any licensed provider can take over your care.

Found Health and Mochi Health are two programs built around ongoing clinical engagement. Found assigns a care team that includes physician oversight and behavioral coaching (Found program overview, verified April 2026). Mochi offers unlimited physician and dietitian access with flat medication pricing that doesn't increase as your dose escalates (Mochi Health, verified April 2026).

A Practical Checklist

Before concluding the medication isn't working, work through this:

1. Check your timeline. If you're under three months in at a starter or mid-level dose, you're likely measuring too early.
2. Confirm your current dose. Know exactly what you're injecting, what the target dose is, and when you're expected to reach it.
3. Review adherence. Have you missed doses? Are you storing the medication correctly? Are you rotating injection sites?
4. Evaluate your compounded product. If you're using compounded semaglutide, ask your pharmacy for a certificate of analysis. Not all formulations are equivalent.
5. Talk to your provider. Ask directly about titration, progress expectations, and whether a medication switch is appropriate.
6. Consider your options if support is lacking. You can switch providers. Most telehealth platforms handle transitions with a standard intake process.

If you've been through this list honestly and things still aren't moving at a fully titrated dose with consistent adherence, a conversation about tirzepatide or a metabolic workup is the right next step. Not every person responds identically to every GLP-1 medication, and that's not a failure — it's information.

Find a program that matches where you are: take the RxPickr GLP-1 quiz to see which provider fits your current situation.

GLP-1 medications require a prescription. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before changing your dose, switching medications, or making decisions about your treatment plan.